Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Human Reproduction

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HUMREP/DEH873PMID 15802320
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

  2004cited by this paper
• Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.

  2004influential reference
• Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

  2004influential reference
• Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics.

  2004influential reference
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

  2003influential reference
• Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

  2003influential reference
• Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

  2003cited by this paper
• Anti-Müllerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary.

  2002influential reference
• Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.

  2002influential reference
• Antimüllerian hormone serum levels: a putative marker for ovarian aging.

  2002cited by this paper
• Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

  2002cited by this paper
• Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.

  2002cited by this paper
• Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary.

  2001cited by this paper
• Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability.

  2000cited by this paper
• Androgens stimulate early stages of follicular growth in the primate ovary.

  1998cited by this paper
• Müllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis.

  1997cited by this paper
• Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles.

  1997influential reference
• Location and developmental regulation of androgen receptor in primate ovary.

  1997cited by this paper
• Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

  1995cited by this paper
• Androgen response in polycystic ovarian syndrome to FSH treatment after LHRH agonist suppression.

  1992cited by this paper
• A quantitative and interspecific test for biological activity of anti-müllerian hormone: the fetal ovary aromatase assay.

  1992cited by this paper
• Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?

  1991cited by this paper
• FOLLICULAR FLUID CONCENTRATIONS OF INSULIN‐LIKE GROWTH FACTOR 1, EPIDERMAL GROWTH FACTOR, TRANSFORMING GROWTH FACTOR‐ALPHA AND SEX‐STEROIDS IN VOLUME MATCHED NORMAL AND POLYCYSTIC HUMAN FOLLICLES

  1990cited by this paper
• Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells.

  1986cited by this paper

• The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance

  2025cites this paper
• Variability of anti-Müllerian hormone and folliculotropic hormone levels in women of reproductive age in relation to normal or impaired ovarian function

  2025cites this paper
• Animal models of polycystic ovary syndrome

  2025cites this paper
• Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome

  2024cites this paper
• Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS

  2024cites this paper
• Assessing body composition through anthropometry: Implications for diagnosing and managing polycystic ovary syndrome (PCOS)

  2024cites this paper
• Granulosa cell-derived miR-379-5p regulates macrophage polarization in polycystic ovarian syndrome

  2023cites this paper
• Value of Assessing AMH in the Management of Polycystic Ovarian Syndrome (PCOS)

  2023cites this paper
• Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes

  2023cites this paper
• The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome

  2023cites this paper
• Anti-Müllerian Hormone Inhibits FSH-Induced Cumulus Oocyte Complex In Vitro Maturation and Cumulus Expansion in Mice

  2022cites this paper
• Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?

  2022cites this paper
• A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)

  2022cites this paper
• The Role of a High-Fat, High-Fructose Diet on Letrozole-Induced Polycystic Ovarian Syndrome in Prepubertal Mice

  2022cites this paper
• Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance.

  2021cites this paper
• Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS

  2021cites this paper
• Metabolic and Reproductive Disorders in Girls with a Premature Pubarchе

  2021cites this paper
• Impact of Polycystic Ovary Syndrome, Metabolic Syndrome, Obesity, and Follicular Growth Arrest in Women Health

  2021cites this paper
• INTERRELATIONSHIP OF AMH WITH CLINICAL, HORMONAL AND SONOGRAPHIC PARAMETERS IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE

  2021cites this paper
• Reproductive Deficits Induced by Prenatal Anti-Mullerian Hormone Exposure Require Androgen Receptor in Kisspeptin Cells.

  2021cites this paper
• High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients

  2021cites this paper
• Association between hyperandrogenism and adverse pregnancy outcomes in patients with different polycystic ovary syndrome phenotypes undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis

  2021cites this paper
• Prevalence of oligomenorrhea among women of childbearing age in China: A large community-based study

  2020cites this paper
• Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis

  2020cites this paper
• Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.

  2020cites this paper
• Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.

  2020cites this paper
• Contribution of recruitable follicles to circulating anti-Müllerian hormone levels following maximal gonadotrophin stimulation in patients with limited ovarian reserve

  2020cites this paper
• Hormone Imbalance in Women with Infertility Caused by Polycystic Ovary Syndrome: Is There a Connection with Body Mass Index?

  2020cites this paper
• Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome

  2020cites this paper
• PCOS

  2019cites this paper
• Animal Models for Human Polycystic Ovary Syndrome (PCOS) Focused on the Use of Indirect Hormonal Perturbations: A Review of the Literature

  2019cites this paper
• Correlation of serum androgen and gonadotropin with anti-mullerian hormone in polycystic ovarian syndrome in Eastern Indian population

  2019cites this paper
• Anti-Müllerian Hormone (AMH) in Adults

  2019cites this paper
• Anti-Mullerian Hormone as A new Marker for Diagnosis of Poly Cystic Ovary Syndrome

  2019cites this paper
• Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes

  2019cites this paper
• Anti – Mullerian Hormone is a new Marker for Ovarian function in females with polycystic ovary syndrome

  2019cites this paper
• Anti Müllerian Hormone: More than a biomarker of female reproductive function.

  2019cites this paper
• The Effect of Resistance Training in Water and Land with Vitamin D Supplementation on Anti-Mullerian Hormone in Women with Polycystic Ovary Syndrome

  2019cites this paper
• Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight polycystic ovary syndrome women

  2018cites this paper
• Tetragonia tetragonioides (Pall.) Kuntze Regulates Androgen Production in a Letrozole-Induced Polycystic Ovary Syndrome Model

  2018cites this paper
• Reproductive and metabolic determinants of granulosa cell dysfunction in normal-weight women with polycystic ovary syndrome.

  2018cites this paper
• The correlation between serum AMH and HOMA-IR among PCOS phenotypes

  2018cites this paper
• Follicle Excess and Abnormalities in Women with PCOS: Pathophysiology, Assessment and Clinical Role

  2018cites this paper
• Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women

  2018cites this paper
• Anti-Müllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters

  2018cites this paper
• Research progress on anti-mullerian hormone clinical applications and immunoassay development

  2018cites this paper
• Anti-mullerian hormone and antral follicle count in polycystic ovary syndrome and non-polycystic ovary syndrome women

  2018cites this paper
• The Regulation of Ovarian Follicular Growth by Anti-Müllerian Hormone

  2018cites this paper
• Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome

  2018cites this paper
• Undetectable Serum Levels of Anti-Müllerian Hormone in Women with Ovarian Hyperstimulation Syndrome during In Vitro Fertilization and Successful Pregnancy Outcome: Case Report

  2018cites this paper
• Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH

  2017cites this paper
• Anti‐Müllerian hormone reflects the severity of polycystic ovary syndrome

  2017cites this paper
• Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes

  2017influential citation
• Is foetal hyperexposure to androgens a cause of PCOS?

  2017cites this paper
• Anti-Mullerian Hormone (AMH) Determinations in the Pediatric and Adolescent Endocrine Practice.

  2017cites this paper
• The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome

  2017cites this paper
• High-fat high-sugar diet induces polycystic ovary syndrome in a rodent model†

  2017cites this paper
• Влияние комбинации сибутрамин/метформина гидрохлорид на уровень антимюллерова гормона в терапии синдрома поликистозных яичников у женщин с метаболическим синдромом

  2016cites this paper
• Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value

  2016cites this paper
• A challenge in the management of women with polycystic ovary syndrome.

  2016cites this paper
• Is anti-Mullerian hormone an indicator of potential polycystic ovary syndrome in prepubertal girls with simple obesity?

  2016cites this paper
• Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.

  2016cites this paper
• The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

  2016cites this paper
• Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome

  2016cites this paper
• THE ROLE OF ANTI-MULLERIAN HORMONE IN THE EVALUATION OF THE EFFECTIVENESS OF METFORMIN HYDROCHLORIDE THERAPY IN POLYCYSTIC OVARIAN SYNDROME

  2016cites this paper
• Anti-Mullerian Hormone and Follicle Stimulating Hormone as Markers of Ovarian Agingin a Sample of Iraqi Women

  2016cites this paper
• Plasma anti-Müllerian hormone as a predictive endocrine marker to select Bos taurus (Holstein) and Bos indicus (Nelore) calves for in vitro embryo production.

  2016cites this paper
• The effect of environmental, physical, and nutritional factors on in vitro fertilisation

  2016cites this paper
• Plasma anti-Müllerian hormone as a predictive endocrine marker to select Bos taurus (Holstein) and Bos indicus (Nelore) calves for in vitro embryo production

  2016cites this paper
• Anti-mullerian hormone as a diagnostic marker in women with polycystic ovary syndrome

  2016cites this paper
• The role of AMH in the pathophysiology of polycystic ovarian syndrome.

  2016cites this paper
• Evaluation of Serum Anti-Mullerian Hormone ( AMH ) and Plasma Metastin Levels in Women with Polycystic Ovary Syndrome ( PCOS )

  2016cites this paper
• La hormona antimülleriana como marcador de función ovárica

  2016cites this paper
• The relationship between Anti-müllerian hormone and the clinical, biochemical and sonographic parameters in women with polycystic ovarian syndrome

  2016cites this paper
• Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.

  2015cites this paper
• Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case–control study in normal and diabetic pregnancy

  2015cites this paper
• Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients

  2015cites this paper
• Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review

  2015cites this paper
• RELATIONSHIP OF BODY MASS INDEX WITH OVARIAN RESERVE STATUS OF INFERTILE WOMEN MEASURED BY ANTI-MÜLLERIAN HORMONE LEVEL

  2015cites this paper
• The Relation of Serum Anti-Mullerian Hormone with Polycystic Ovary Syndrome: Correlation with Clinical and Hormonal Parameters

  2015cites this paper
• Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome

  2015cites this paper
• Ideal value of serum anti-Mullerian hormone as a predictor of ovarian reserve and outcome in assisted reproductive technology

  2015cites this paper
• Role of Anti-Müllerian Hormone in Gynecology: A Review of Literature

  2015cites this paper
• Androgens as double-edged swords: Induction and suppression of follicular development

  2015cites this paper
• The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome

  2015cites this paper
• Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?

  2015cites this paper
• Lack of Serum anti-Mullerian hormone responses after recombinant human chorionic gonadotropin stimulation in women with polycystic ovary syndrome.

  2015cites this paper
• Niveles de hormona antimülleriana en pacientes con síndrome de ovario poliquístico

  2015cites this paper
• Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.

  2015cites this paper
• Serum anti-Mullerian hormone level as a marker of polycystic ovarian syndrome in Iraqi women

  2015cites this paper
• AMH levels at central precocious puberty and premature thelarche: is it a parameter?

  2015cites this paper
• The physiology and clinical utility of anti-Mullerian hormone in women.

  2014cites this paper
• The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.

  2014cites this paper
• Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients

  2014cites this paper
• Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms

  2014cites this paper
• May AMH levels distinguish LOCAH from PCOS among hirsute women?

  2014cites this paper
• Dynamics of anti-Müllerian hormone during controlled ovarian stimulation

  2014cites this paper
• Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.

  2014cites this paper
• Serum anti-Müllerian hormone and polycystic ovary syndrome: a matter of methods?

  2014cites this paper
• Effects of 8 weeks pilates training on anti-Mullerian hormone level and cardiometabolic parameters in polycystic ovary syndrome women

  2014cites this paper